The page is the record's research on the issuer — no analyst, no rating, no view. # Celldex Therapeutics, Inc. (NASDAQ: CLDX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Celldex Therapeutics, Inc., listed on NASDAQ under ticker CLDX, ISIN US15117B2025, LEI 529900F018DMYWH38923. Its security type is Corporate, its sector is 2835 In Vitro & In Vivo Diagnostic Substances, and its jurisdiction is United States, Delaware. Segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 61 filings across 29 filing days in the window 2025-11-08 to 2026-11-08. The filings are 24 directors' dealings, 19 regulatory filings, 10 results, 3 prospectuses, 2 corporate news, 2 director changes, and 1 AGM/EGM. The median gap between filing days is 8.5 days. The latest filing is a results filing dated 2026-11-05, three days before the record date. The NASDAQ peer median cadence gap is 6.0 days, the NASDAQ peer median filings figure is 52, and the NASDAQ peer median latency is 5.0 days. The sector peer median cadence gap is 6.5 days, the sector peer median filings figure is 61, and the sector peer median latency is 4 days. ## Auditor The auditor of record is PricewaterhouseCoopers LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0000744218.json (identity.jurisdiction) - https://api.gleif.org/api/v1/lei-records/529900F018DMYWH38923 (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/CLDX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/744218/000110465926019652/cldx-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CLDX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CLDX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp